News Posts

• Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock

• InMed Announces Pricing of US $8.0 Million Public Offering and Listing on the Nasdaq Capital Market Under the Symbol “INM”

• 9 Meters Biopharma, Inc. Prices Public Offering of Common Stock

• BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market

• BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market

• SCYNEXIS Announces Pricing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

• Big Cypress Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

• Nova Vision Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering

• Celsion Corporation Announces $35 Million Registered Direct Offering Priced At-The-Market